Day: January 28, 2025

Euronext to acquire Nasdaq’s Nordic power futures business

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

Euronext to acquire Nasdaq’s Nordic power futures business Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris / New York – 28 January 2025 – Euronext (Euronext: ENX), the leading European capital market infrastructure, and Nasdaq (Nasdaq: NDAQ), a leading transatlantic market operator and global technology company, today announced the signing of a binding agreement under which Euronext will acquire Nasdaq’s Nordic power futures business, subject to receipt of applicable regulatory approvals. The agreement entails the transfer of existing open positions in Nasdaq’s Nordic power derivatives, currently held in Nasdaq Clearing, to Euronext Clearing, with approval of the members. Trading of power futures will be operated from Euronext Amsterdam and will be cleared through Euronext Clearing. Nasdaq Clearing AB, Nasdaq Oslo ASA, and...

Abivax Publishes 2025 Financial Calendar

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Abivax Publishes 2025 Financial Calendar PARIS, France – January 28, 2025 – 8:30 AM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company developing innovative therapies to address chronic inflammatory diseases, today published its expected 2025 financial communications calendar. Monday, March 24, 2025 (after US Market closes) 2024 Annual Business and Financial Report (as of December 31, 2024)Press Release Universal Registration Document (Euronext) Annual Report on Form 20-FMonday, June 2, 2025 (after US Market closes) 2025 Q1 Financial Results (as of March 31, 2025)Press Release Report on Form 6-KFriday, June 6, 2025 2025 Annual General Meeting (AGM)Live meeting in Paris, FranceMonday, August 11, 2025 (after US Market closes) 2025...

Implementation of share buyback programme

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Nasdaq CopenhagenEuronext Dublin London Stock ExchangeDanish FSAOther stakeholders Date 28 January 2025 Implementation of share buyback programme In accordance with the corporate announcement pf 20 November 2024, the bank will implement a new share buyback programme of DKK 500 million for cancellation at a future general meeting. The share buyback programme is based on the general authority which the bank’s annual general meeting of 28 February 2024 granted to the board of directors, enabling the bank to acquire its own shares. The share buyback programme runs in the period 28 January 2025 up to and including 28 May 2025 provided that the forthcoming annual general meeting, to be held on 5 March 2024, gives the board a new authority to permit the bank to acquire its own shares. During the period the bank will thus buy back its own shares...

Share buyback programme – conclusion

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeDanish Financial Supervisory AuthorityOther stakeholders 28 January 2025 Share buyback programme – conclusion Part II of the share buyback programme amounts to DKK 775 million of the total DKK 1,525 million share buyback programme has now been completed and exercised to the sum of DKK 775 million. The combined share buyback programme has been exercised to the sum of DKK 1,525 million. The buybacks for Part II were executed in the period from 28 June 2024 up to and including 27 January 2025. Parts I and II of the share buyback programme are implemented in compliance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) No 2016/1052 of 8 March 2016, which together constitute the Safe Harbour rules. The...

EXEL Industries: First quarter 2024–2025 sales down 19.0%

Written by Customer Service on January 28, 2025. Posted in Public Companies.

First quarter 2024-2025 revenue down 19.0% First quarter impacted by a downturn in agricultural sales, but other activities holding up well3-month revenue(October 2024-December 2024)) 2023-2024 2024-2025 Change (reported) Change (LFL*)Reported Reported €m % €m %AGRICULTURAL SPRAYING 90.9 62.2 -28.8 -31.6% -28.7 -31.6%SUGAR BEET HARVESTING 27.1 19.1 -8.0 -29.4% -8.0 -29.5%LEISURE 11.1 12.9 +1.8 +16.3% +1.2 +10.7%INDUSTRY 71.0 67.8 -3.2 -4.5% -3.2 -4.6%EXEL Industries Group 200.1 162.0 -38.1 -19.0% -38.8 -19.4%* Like-for-like (LFL) = at constant consolidation scope and foreign exchange rates First quarter 2024-2025 revenueThe EXEL Industries Group posted revenue of €162.0 million for the first quarter...

ING to sell its business in Russia to Global Development JSC

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

ING to sell its business in Russia to Global Development JSC ING announced today that it has reached an agreement on the sale of its business in Russia to Global Development JSC, a Russian company owned by a Moscow-based financial investor with a background in factoring services. This transaction will effectively end ING’s activities in the Russian market. Under the terms of the agreement, Global Development will acquire all shares of ING Bank (Eurasia) JSC, taking over all Russian onshore activities and staff. Global Development intends to continue to serve customers in Russia under a new brand. The transaction, which has been preceded by extensive due diligence, is subject to various regulatory approvals and is expected to be closed in the third quarter of 2025. Since February 2022, ING has taken on no new business with Russian companies,...

Virtualware announces uplisting process to Euronext Growth

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Paris, 28 January 2025 – Virtualware (EPA: MLVIR), a pioneer in 3D-driven enterprise software, today initiated its uplisting process to the Euronext Growth segment. Speaking from Madrid, Unai Extremo, the company’s CEO, emphasized that the move aims to enhance market liquidity and investor access. Our uplisting to Euronext Growth is a calculated step in our Strategic Plan we made public a few months ago,” Extremo said. “It reflects our commitment to providing greater liquidity and transparency to our shareholders.” The company expects receiving Euronext’s approval for its listing application during the second quarter 2025, in accordance with the standard listing review process. Euronext is a federation of exchanges comprising the Paris, Amsterdam, Brussels, Oslo, Milan, Lisbon and Dublin markets. Meanwhile, Euronext Growth...

TravelPerk Raises $200M and Acquires Yokoy to Create the Leading Integrated Travel and Expense Management Platform

Written by Customer Service on January 28, 2025. Posted in Mergers And Acquisitions.

The acquisition of Yokoy, a leading spend management platform, allows TravelPerk to offer a deeper and more unified travel and expense offering to its clients while expanding its addressable opportunity. The $200m Series E financing raises the company’s valuation to $2.7 billion. It will accelerate TravelPerk’s continued expansion into the US alongside further investments into product and AI. Atomico, EQT Growth, Noteus Partners and Sequoia Capital will join TravelPerk’s world-class investor base alongside existing investors like General Catalyst, Kinnevik, Softbank Vision Fund, and Blackstone.BARCELONA, Spain and ZURICH, Jan. 28, 2025 (GLOBE NEWSWIRE) — TravelPerk, the leading business travel platform, today announces a new Series E fundraise of $200m. The investment is led by European venture capital firm Atomico,...

Netcompany – Interim report for the 12 months ended 31 December 2024 and Annual Report 2024

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Company announcement No. 06/2025 28 January 2025 Continued growth and margin improvement in a challenging marketSummary full year 2024For the full year, Netcompany grew revenue by 7.6% (constant 7.4%) to DKK 6,540.6m, in line with guidance. Adjusted EBITDA was DKK 1,097.9m in 2024 compared to DKK 901.2m in 2023. Adjusted EBITDA margin was 16.8% for 2024 (constant 16.9%) compared to 14.8% in 2023. Average workforce increased to 8,007 FTEs. Free cash flow in 2024 was DKK 821.1m compared to DKK 552.1m in 2023. Cash conversion ratio increased to 147.1% in 2024 from 135.1% in 2023. Debt leverage was 1.2x. For 2025, Netcompany expects revenue growth in constant currencies of between 5% and 10% and adjusted EBITDA margin measured in constant currencies is expected to be between 16% and 19%.Performance...

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Written by Customer Service on January 28, 2025. Posted in Public Companies.

Allschwil, Switzerland, January 28, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that the sales in 2024 of the antifungal Cresemba® (isavuconazole) and the antibiotic Zevtera® (ceftobiprole) exceeded thresholds triggering sales milestone payments from distribution partners to Basilea, in the total amount of approximately CHF 2.2 million. For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma Pharmaceuticals LLC. For Zevtera, this reflects a milestone payment in Europe, by Advanz Pharma. David Veitch, Chief Executive Officer, said: “We are very...

Day: January 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals